Literature DB >> 15569408

Aspirin protected against endothelial damage induced by LDL: role of endogenous NO synthase inhibitors in rats.

Sheng Deng1, Pan-yue Deng, Jun-lin Jiang, Feng Ye, Jing Yu, Tian-lun Yang, Han-du Deng, Yuan-jian Li.   

Abstract

AIM: To study the protective effect of aspirin on damages of the endothelium induced by low-density lipoprotein (LDL), and whether the protective effect of aspirin is related to reduction of nitric oxide synthase inhibitor level.
METHODS: Vascular endothelial injury was induced by a single injection of native LDL (4 mg/kg) in rats. Vasodilator responses to acetylcholine (ACh) in the isolated aortic rings were determined, and serum concentrations of asymmetric dimethylarginine (ADMA), malondialdehyde (MDA), tumour necrosis factor-alpha (TNF-alpha), and the activity of dimethylaminohydrolase (DDAH) were measured.
RESULTS: A single injection of LDL (4 mg/kg) significantly decreased vasodilator responses to ACh, increased the serum level of ADMA, MDA, and TNF-alpha, and decreased DDAH activity. Aspirin (30 or 100 mg/kg) markedly reduced the inhibition of vasodilator responses to ACh by LDL, and the protective effect of aspirin at the lower dose was greater compared with high-dose aspirin group. Aspirin inhibited the increased level of MDA and TNF-alpha induced by LDL. Aspirin at the dose of 30 mg/kg, but not at higher dose (100 mg/kg), significantly reduced the concentration of ADMA and increased the activity of DDAH.
CONCLUSION: Aspirin at the lower dose (30 mg/kg) protects the endothelium against damages elicited by LDL in vivo, and the protective effect of aspirin on endothelium is related to reduction of ADMA concentration by increasing DDAH activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569408

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  9 in total

1.  Non-steroidal anti-inflammatory drugs attenuate the vascular responses in aging metabolic syndrome rats.

Authors:  María Esther Rubio-Ruiz; Israel Pérez-Torres; Eulises Diaz-Diaz; Natalia Pavón; Verónica Guarner-Lans
Journal:  Acta Pharmacol Sin       Date:  2014-09-29       Impact factor: 6.150

Review 2.  Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

Authors:  Chris Baylis
Journal:  Nat Clin Pract Nephrol       Date:  2006-04

3.  Comparative effects of cilostazol and aspirin on the impairment of endothelium-dependent cerebral vasodilation caused by acute cigarette smoking in rats.

Authors:  Hiroki Iida; Mami Iida; Motoyasu Takenaka; Naokazu Fukuoka; Shuji Dohi
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

Review 4.  The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis.

Authors:  James Leiper; Manasi Nandi
Journal:  Nat Rev Drug Discov       Date:  2011-04       Impact factor: 84.694

5.  The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease.

Authors:  Latika Sibal; Sharad C Agarwal; Philip D Home; Rainer H Boger
Journal:  Curr Cardiol Rev       Date:  2010-05

6.  Assessment of the relationship between asymmetric dimethylarginine and severity of erectile dysfunction and coronary artery disease.

Authors:  Tevfik Aktoz; Meryem Aktoz; Ersan Tatlı; Mustafa Kaplan; Fatma N Turan; Ahmet Barutcu; Irfan H Atakan; Muzaffer Demir; Armagan Altun
Journal:  Int Urol Nephrol       Date:  2010-01-21       Impact factor: 2.370

7.  Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease.

Authors:  Scott S Billecke; Louis G D'Alecy; Raylene Platel; Steven E Whitesall; Kenneth A Jamerson; Rachel L Perlman; Crystal A Gadegbeku
Journal:  Nephrol Dial Transplant       Date:  2008-09-15       Impact factor: 5.992

8.  Proteomic investigation of effects of hydroxysafflor yellow A in oxidized low-density lipoprotein-induced endothelial injury.

Authors:  Feng Ye; Jianhe Wang; Wei Meng; Jingru Qian; Ming Jin
Journal:  Sci Rep       Date:  2017-12-21       Impact factor: 4.379

Review 9.  Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?

Authors:  Anna Czarnecka; Krzysztof Milewski; Magdalena Zielińska
Journal:  Neurochem Res       Date:  2016-11-25       Impact factor: 3.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.